PET/CT in prostate cancer: non-choline radiopharmaceuticals.
about
(11)C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study.PET imaging of recurrent and metastatic prostate cancer with novel tracers.Preliminary clinical experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT imaging in prostate cancer patients.Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.
P2860
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@ast
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@en
type
label
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@ast
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@en
prefLabel
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@ast
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@en
P2860
P1476
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
@en
P2093
P Castellucci
P2860
P304
P577
2012-08-01T00:00:00Z